[Treatment of neoplasms with partial synchronization of cell proliferation].
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004347:Drug Interactions; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008722:Methods; D008938:Mitosis / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D011241:Prednisone
Zasady terapii nowotworów z cześciowa synchronizacja proliferacji komórek.